Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972481-24-000216
Filing Date
2024-09-03
Accepted
2024-09-03 16:36:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2961
  Complete submission text file 0001972481-24-000216.txt   4518
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Subject) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40674 | Film No.: 241274603
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 20 FIRSTFIELD ROAD, #250 GAITHERSBURG MD 20878
Business Address
Erck Stanley C (Reporting) CIK: 0001342826 (see all company filings)

Type: 144